Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis

Effective drug development to combat metastatic disease in breast cancer would be aided by the availability of well-characterized preclinical animal models that (a) metastasize with high efficiency, (b) metastasize in a reasonable time-frame, (c) have an intact immune system, and (d) capture some of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yang, Yuan, Yang, Howard H., Hu, Ying, Watson, Peter H., Liu, Huaitian, Geiger, Thomas R., Anver, Miriam R., Haines, Diana C., Martin, Philip, Green, Jeffrey E., Lee, Maxwell P., Hunter, Kent W., Wakefield, Lalage M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Priority Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458155/
https://ncbi.nlm.nih.gov/pubmed/28430642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15695
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars